Please use this identifier to cite or link to this item:
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/3602
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Malwal, Satish | en_US |
dc.contributor.author | Sriram, Dharmarajan | en_US |
dc.contributor.author | Yogeeswari, Perumal | en_US |
dc.contributor.author | Konkimalla, V. Badireenath | en_US |
dc.contributor.author | CHAKRAPANI, HARINATH | en_US |
dc.date.accessioned | 2019-07-23T11:08:15Z | |
dc.date.available | 2019-07-23T11:08:15Z | |
dc.date.issued | 2011-11 | en_US |
dc.identifier.citation | The Journal of Medicinal Chemistry, 55(1), 553-557. | en_US |
dc.identifier.issn | 0022-2623 | en_US |
dc.identifier.issn | 1520-4804 | en_US |
dc.identifier.uri | http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/3602 | - |
dc.identifier.uri | https://doi.org/10.1021/jm201023g | en_US |
dc.description.abstract | Here, 2,4-dinitrophenylsulfonamides with tunable cysteine-activated SO2 release profiles with half-lives of SO2 release varying from 2 to 63 min are reported. N-Benzyl-2,4-dinitrobenzenesulfonamide (6), which is prepared in one step from commercial sources, had a potency (MIC = 0.15 μM) of inhibiting Mycobacterium tuberculosis (Mtb) higher than the clinical agent isoniazid (MIC = 0.37 μM). | en_US |
dc.language.iso | en | en_US |
dc.publisher | American Chemical Society | en_US |
dc.subject | Chemistry | en_US |
dc.subject | 2011 | en_US |
dc.title | Design, Synthesis, and Evaluation of Thiol-Activated Sources of Sulfur Dioxide (SO2) as Antimycobacterial Agents | en_US |
dc.type | Article | en_US |
dc.contributor.department | Dept. of Chemistry | en_US |
dc.identifier.sourcetitle | The Journal of Medicinal Chemistry | en_US |
dc.publication.originofpublisher | Foreign | en_US |
Appears in Collections: | JOURNAL ARTICLES |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.